Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 12:47 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | FL | 50 beds | Grade D | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 103047 | HILLSBOROUGH, FL | 50 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 50-bed community hospital in HILLSBOROUGH, FL with $25.1M in net patient revenue and a 5.2% operating margin. The hospital serves a payer mix of 69.2% Medicare, 0.0% Medicaid, and 30.8% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.2% to 12.5% (+736bps).

Net Revenue HCRIS$25.1M
Current EBITDA COMPUTED$1.3M
Operating Margin COMPUTED5.2%
Occupancy HCRIS89.1%
Revenue / Bed COMPUTED$502K
Net-to-Gross HCRIS60.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
95
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 5.2% places it above the state median. Among 95 size-comparable peers (25-100 beds), the median margin is 3.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 95 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)FL50$25.1M5.2%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
ASCENSION SACRED HEART EMERALDFL80$187.9M16.1%
VIERA HOSPITAL INCFL84$162.9M16.9%
GULF BREEZE HOSPITALFL65$121.8M12.8%
MELBOURNE REGIONAL MEDICAL CENFL96$120.2M7.3%
LOWER KEYS MEDICAL CENTERFL99$119.5M27.1%
OVIEDO MEDICAL CENTERFL64$110.9M7.4%
HCA FLORIDA POINCIANA HOSPITALFL94$108.5M18.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$527K+210bp18mo
Cost to Collect4.5%2.5%$502K+200bp12mo
Denial Rate Reduction12.0%6.5%$497K+198bp12mo
A/R Days Reduction5200.0%3800.0%$306K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$527K
Cost to Collect
$502K
Denial Rate Reduction
$497K
A/R Days Reduction
$306K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.8M
Current EBITDA$1.3M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$3.2M
Current Margin5.2%
Pro Forma Margin12.5%
WC Released (1x)$963K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.0M$27.1M13.52x68.3%
Base (11x exit)10.0x11.0x$2.0M$30.4M15.20x72.3%
Bull Case9.0x11.0x$1.8M$37.2M20.64x83.2%
Bull (12x exit)9.0x12.0x$1.8M$41.1M22.81x86.9%
Bear Case11.0x10.0x$2.2M$17.2M7.80x50.8%
Bear (11x exit)11.0x11.0x$2.2M$19.6M8.91x54.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 69.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 95 hospitals with 25-100 beds
  • Same-state prioritization (n=96)
  • Comp margins: P25=-15.2% / P50=3.9% / P75=11.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.